In particular, in recent times, RNA-seq has increasingly been used to detect translocations or splicing alterations that can have a predictive value in cancer (for example, ALK, ROS1, RET and NTRK fusions and MET exon 14 skipping mutations in NSCLC) [36,37]. Here, ROS1 is linked to non-small cell lung carcinoma.